ArticleClinical and translational science2022

Polypharmacy influences the renal composite outcome in patients treated with sodium-glucose cotransporter 2 inhibitors.

Kazuo Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.